Discussion | Human Germline Modification: Medicine, Science, Ethics, and Law
2,131 views · Published 2 June 2015 · 1:25:39 · Indexed 12 November 2026
Channel: Stanford Law School · 2015 · Education
On May 14th, Stanford's Center for Law and the Biosciences and Stanford's Phi Beta Kappa Chapter co-hosted a panel event on editing the human germline genome, entitled "Human Germline Modification: Medicine, Science, Ethics, and Law.” The event brought together top scholars and experts to discuss the law, ethics, and science behind CRISPR-CAS9 generally, and its application to the human germline more specifically. The speaker line-up included Marcy Darnovsky, Executive Director of the Center for Genetics and Society; CLB's Hank Greely; Paul Knoepfler, Professor of Cell Biology and Human Anatomy, UC Davis School of Medicine; Christopher Thomas Scott, Director, Stanford Program on Stem Cells in Society, and; Lynn Westphal, Professor of Obstetrics and Gynecology, Stanford University Medical School.
More from this channel
-
1:57:29
Debate | The Goldstone Report: A Debate
-
32:15
Stanford Law and Memory Conference- Reconsolidation in Human Memory - Almut Hupbach
-
28:17
Law and Memory Conference: Creating Lasting Memories -- James McGaugh
-
57:47
Discussion | Saving The Media From Itself with David Westin
-
1:16:49
Channeling Justice | Facts and Fantasies About Lawyers on Television
-
1:29:55
Discussion | When States Go Broke: The Pros, Cons, and Mechanics of State Bankruptcy
-
0:23
Dedication | SLS Students React To New Stanford Law School Building
-
1:46:28
STLR Symposium | Emerging Issues of Secondary Liability Copyright Law